Company / Working Capital per Share
Niagen Bioscience, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.99
FY2025
5-year range
$0.39 / $0.99
FY2021-FY2025
Trend
+61.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has fluctuated over the past 10 years, ranging from $0.19 in FY2016 to $335.00 in FY2019.
Based on SEC 10-K filings.
0.99 in FY2025 with a 5-year CAGR of +30.3%.
Improved from $0.39 to $0.99 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +33.1%
- 5-Year CAGR
- +30.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share increased 61.5% year-over-year.
- Peak working capital per share was recorded in FY2019.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.99 | +61.5% |
| FY2024 | $0.62 | +58.8% |
| FY2023 | $0.39 | -8.0% |
| FY2022 | $0.42 | -16.7% |
| FY2021 | $0.51 | +91.3% |
| FY2020 | $0.26 | -99.9% |
| FY2019 | $335.00 | +82835.1% |
| FY2018 | $0.40 | -69.1% |
| FY2017 | $1.31 | +585.4% |
| FY2016 | $0.19 | +188.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026